Search Tag: Board of Directors
2024 28 Mar
BRIJ Medical proudly welcomes three distinguished industry leaders to its Board of Directors: John Grotting , Bob Zollars , and Jim Hinrichs . Leveraging their extensive experience and insights, they will steer the company's strategic vision and drive future growth initiatives for BRIJ's incision and scar management technologies....Read more
2024 05 Jan
Current CEO, Craig Meier, to become Vice Chairman of the Board of Directors Medical Solutions announced the appointment of Rebecca Rogers Tijerino as CEO, effective Feb. 1, 2024. At that time, Craig Meier, who has served as CEO since 2014, will become Vice Chairman of the Company’s Board of Directors and focus on strategy and M&A initiatives....Read more
2023 03 Aug
Algorics Inc., one of the fastest-growing biometrics and data science companies announced the addition of three new members to its board and leadership team, to accelerate its growth and strengthen strategic direction. The newly appointed members are Alan Morgan as a Member of the Board, Greg Steffens as Strategic Advisor, and Stephen Boccardo as...Read more
2023 24 Jul
BD, a leading global medical technology company announced the appointment of Dr. Joanne Waldstreicher to its board of directors. Waldstreicher, 63, was most recently the chief medical officer for Johnson & Johnson (J&J), serving in this capacity from 2012 until her retirement in 2023. As chief medical officer, she provided visionary strategic and...Read more
2023 24 Jul
MapLight Therapeutics, a clinical-stage biopharmaceutical company working to develop targeted, novel therapeutics to improve the lives of people with brain disorders announced the appointment of Tim Garnett, M.D. to its Board of Directors. Dr. Garnett is a pharmaceutical executive with decades of experience in drug development and strategic portfolio...Read more
2023 24 Jul
STRM.BIO, a pre-clinical, VC-backed biotechnology company that is leveraging extracellular vesicles (EVs) to deliver gene therapies and developing new therapeutics for rare blood diseases announced the appointment of Minnie Mildwoff, to its Board of Directors. Ms. Mildwoff has been a member of the company's Scientific Advisory Board (SAB) since May...Read more
2023 10 Jul
Inflammatix, a pioneering molecular diagnostics company, announced the appointment of Heiner Dreismann, PhD, as a member of the company's board of directors. Inflammatix appoints former Roche Molecular Systems CEO Heiner Dreismann, PhD, to its Board of Directors. Dr. Dreismann brings to Inflammatix more than 35 years of experience in the life...Read more
2023 20 Apr
Homecare Hub, a company creating innovative home care and housing solutions, is pleased to announce the appointment of one of the world's top health systems leaders, Dr. Michael Apkon, MD, MBA, PhD to its Board of Directors. Dr. Apkon is a physician executive and physician scientist who most recently served as the CEO at Tufts Medical Center in...Read more
2023 14 Apr
LivaNova PLC, a market-leading medical technology and innovation company, today announced that Damien McDonald has resigned as Chief Executive Officer. Effective immediately, Chair of the Board William A. Kozy is appointed interim CEO to help the executive leadership team maintain the focus on growth and profitability. The Board has retained a leading...Read more
2023 03 Mar
Quest Diagnostics, the world's leading provider of diagnostic information services announced that its Board of Directors elected James E. Davis, the company's Chief Executive Officer and President, to serve in the additional position of Chairman of the Board of Directors, effective April 1, 2023. "The Board carefully considered our governance structure...Read more
2023 06 Jan
Pneumagen, a clinical stage biotech company developing Neumifil, a broad-spectrum antiviral, intranasal drug for the prophylaxis and treatment of viral respiratory tract infections (RTIs), announces the appointment of James Noble as non-executive Chairman of its Board of Directors. James brings over 30 years of industry experience to the Board...Read more
2022 30 Nov
TigerConnect, healthcare’s most powerful clinical collaboration platform, today announced the appointment of a healthcare executive, Adrienne Kirby, Ph.D., to its board of directors. With over four decades of experience guiding the strategic and operational development of large health systems, physician organizations, and outpatient services, Kirby...Read more
2022 31 Oct
The Nemours Children's Health Board of Directors has announced the election of Gwen M. MacKenzie to the Board, effective immediately. She has more than 30 years of experience leading complex health care organizations through transformation, strategic repositioning, and new service innovation. Ms. MacKenzie is a McKinsey & Company Senior Advisor...Read more
2022 19 Oct
Theseus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development, and commercialization of transformative targeted therapies announced the appointment of Steven Stein , M.D. to its Board of Directors. "We are delighted to welcome Dr. Stein to the Theseus...Read more
2022 13 Oct
Labcorp, a leading global life sciences company announced that Kirsten Kliphouse, president of Americas, Google Cloud, has joined its Board of Directors as an independent member. Kliphouse brings decades of leadership experience honed at some of the world’s most-recognizable technology companies, as well as a proven passion for building teams and...Read more
2022 29 Sep
Comar has named Brian Larkin as its new President and Chief Executive Officer, succeeding Mike Ruggieri, who will transition to the Chairman role and remain on the Board of Directors. Under Mr. Ruggieri’s 15 years of leadership, Comar evolved from a single site family-owned business to a professionally backed, multi-national company with expanded customer...Read more
2022 26 Aug
Everest Medicines , a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs in Asia Pacific markets announced that Dr. Kerry Blanchard has resigned as Chief Executive Officer and as a member of the Board of Directors, effective immediately. He will remain as an advisor...Read more
2022 03 Aug
Amgen announced the appointment of Michael V. Drake, M.D., to its Board of Directors, effective immediately. Dr. Drake will also serve as a member of the Board's Corporate Responsibility and Compliance Committee and its Governance and Nominating Committee. Following the appointment of Dr. Drake, the Board will be composed of 13 directors, 12 of whom...Read more
2022 23 Jun
Tevogen Bio, a late-stage biotechnology company specializing in developing cell and gene therapies in oncology, neurology, and virology announced that its Board of Directors has appointed Kendell R. Sprott, M.D., J.D., to its Corporate Advisory Board. Most recently, Dr. Sprott served six years as President and CEO at Matheny Medical and Educational...Read more
2022 21 Apr
The Urology Care Foundation, the world’s leading nonprofit urological health foundation and official foundation of the American Urological Association, is pleased to announce Brian McNeil, MD, MBA, FACS, has joined the Foundation Board of Directors. Dr. McNeil brings a wealth of expertise in working with patients from underserved areas across the...Read more
2021 14 Dec
Dr. Jorge Gutiérrez-Aceves to support the Association's strategies and activities in the Americas and Caribbean The American Urological Association (AUA) is pleased to announce Jorge Gutiérrez-Aceves, MD has been named by the Board of Directors as AUA Assistant Secretary for the Americas and the Caribbean . Dr. Gutiérrez-Aceves will begin his...Read more
2021 10 Dec
Abbott announced that its Board of Directors has elected Chief Executive Officer Robert B. Ford as Chairman of the Board, effective today. Miles D. White , executive chairman and former CEO, will step down from the Abbott Board effective today and will retire after a remarkable 38-year career with the Company. "We're grateful for Miles' leadership...Read more